ArticlePloS one2024

Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles.

Jennifer Serwanga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.